Literature DB >> 19228877

TRAF2 and TRAF3 independently mediate Ig class switching driven by CD40.

Haifa H Jabara1, Yu Weng, Tatyana Sannikova, Raif S Geha.   

Abstract

The isotype switch defect in CD40(-/-) mice is corrected by wild-type (WT) CD40 transgene, but not by a mutant CD40 transgene that does not bind tumor necrosis factor receptor-associated factors (TRAF) 2 and 3. To define the individual roles of TRAF2 and TRAF3 in CD40 activation of B cells, we introduced mutant CD40 transgenes that selectively lack the ability to bind TRAF2 (DeltaTR2), TRAF3 (DeltaTR3) or both (DeltaTR2,3) into B cells of CD40(-/-) mice. Serum IgG1 and IgE levels, IgG1 antibody response to sub-optimal doses of the T cell-dependent antigen keyhole limpet hemocyanin, germinal center formation, CD40-mediated proliferation, isotype switching and activation of the non-canonical NF-kappaB pathway were partially diminished in DeltaTR2 and DeltaTR3 mice and virtually absent in DeltaTR2,3 mice. These results suggest that TRAF2 and TRAF3 can each independently mediate class switch recombination (CSR) driven by CD40, but both are required for optimal CD40-driven isotype switching.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19228877      PMCID: PMC2721683          DOI: 10.1093/intimm/dxp013

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  43 in total

Review 1.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

Authors:  M Karin; Y Ben-Neriah
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  The CD40-TRAF6 axis controls affinity maturation and the generation of long-lived plasma cells.

Authors:  Cory Ahonen; Eric Manning; Loren D Erickson; Brian O'Connor; Evan F Lind; Steven S Pullen; Marilyn R Kehry; Randolph J Noelle
Journal:  Nat Immunol       Date:  2002-04-22       Impact factor: 25.606

Review 3.  Mechanism and control of class-switch recombination.

Authors:  John P Manis; Ming Tian; Frederick W Alt
Journal:  Trends Immunol       Date:  2002-01       Impact factor: 16.687

4.  Differential role for p38 mitogen-activated protein kinase in regulating CD40-induced gene expression in dendritic cells and B cells.

Authors:  A Aicher; G L Shu; D Magaletti; T Mulvania; A Pezzutto; A Craxton; E A Clark
Journal:  J Immunol       Date:  1999-12-01       Impact factor: 5.422

5.  Tumour-necrosis-factor-receptor-associated factor 6, NF-kappaB-inducing kinase and IkappaB kinases mediate IgE isotype switching in response to CD40.

Authors:  K Brady; S Fitzgerald; P N Moynagh
Journal:  Biochem J       Date:  2000-09-15       Impact factor: 3.857

6.  Essential role of RelB in germinal center and marginal zone formation and proper expression of homing chemokines.

Authors:  D S Weih; Z B Yilmaz; F Weih
Journal:  J Immunol       Date:  2001-08-15       Impact factor: 5.422

7.  Dissection of B cell differentiation during primary immune responses in mice with altered CD40 signals.

Authors:  Teruhito Yasui; Masaaki Muraoka; Yuko Takaoka-Shichijo; Isao Ishida; Noriko Takegahara; Junji Uchida; Atsushi Kumanogoh; Sachiko Suematsu; Misao Suzuki; Hitoshi Kikutani
Journal:  Int Immunol       Date:  2002-03       Impact factor: 4.823

8.  The combined absence of NF-kappa B1 and c-Rel reveals that overlapping roles for these transcription factors in the B cell lineage are restricted to the activation and function of mature cells.

Authors:  Thomas Pohl; Raffi Gugasyan; Raelene J Grumont; Andreas Strasser; Donald Metcalf; David Tarlinton; William Sha; David Baltimore; Steve Gerondakis
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-02       Impact factor: 11.205

9.  Molecular basis for CD40 signaling mediated by TRAF3.

Authors:  C Z Ni; K Welsh; E Leo; C K Chiou; H Wu; J C Reed; K R Ely
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

10.  TACI and BAFF-R mediate isotype switching in B cells.

Authors:  Emanuela Castigli; Stephen A Wilson; Sumi Scott; Fatma Dedeoglu; Shengli Xu; Kong-Peng Lam; Richard J Bram; Haifa Jabara; Raif S Geha
Journal:  J Exp Med       Date:  2005-01-03       Impact factor: 14.307

View more
  9 in total

1.  Identification of sequence variants influencing immunoglobulin levels.

Authors:  Stefan Jonsson; Gardar Sveinbjornsson; Aitzkoa Lopez de Lapuente Portilla; Bhairavi Swaminathan; Rosina Plomp; Gillian Dekkers; Ram Ajore; Mina Ali; Arthur E H Bentlage; Evelina Elmér; Gudmundur I Eyjolfsson; Sigurjon A Gudjonsson; Urban Gullberg; Arnaldur Gylfason; Bjarni V Halldorsson; Markus Hansson; Hilma Holm; Åsa Johansson; Ellinor Johnsson; Aslaug Jonasdottir; Bjorn R Ludviksson; Asmundur Oddsson; Isleifur Olafsson; Sigurgeir Olafsson; Olof Sigurdardottir; Asgeir Sigurdsson; Lilja Stefansdottir; Gisli Masson; Patrick Sulem; Manfred Wuhrer; Anna-Karin Wihlborg; Gudmar Thorleifsson; Daniel F Gudbjartsson; Unnur Thorsteinsdottir; Gestur Vidarsson; Ingileif Jonsdottir; Björn Nilsson; Kari Stefansson
Journal:  Nat Genet       Date:  2017-06-19       Impact factor: 38.330

2.  Interactome mapping of the phosphatidylinositol 3-kinase-mammalian target of rapamycin pathway identifies deformed epidermal autoregulatory factor-1 as a new glycogen synthase kinase-3 interactor.

Authors:  Fanny Pilot-Storck; Emilie Chopin; Jean-François Rual; Anais Baudot; Pavel Dobrokhotov; Marc Robinson-Rechavi; Christine Brun; Michael E Cusick; David E Hill; Laurent Schaeffer; Marc Vidal; Evelyne Goillot
Journal:  Mol Cell Proteomics       Date:  2010-04-05       Impact factor: 5.911

3.  Chemotherapy Coupled to Macrophage Inhibition Induces T-cell and B-cell Infiltration and Durable Regression in Triple-Negative Breast Cancer.

Authors:  Swarnima Singh; Nigel Lee; Diego A Pedroza; Igor L Bado; Clark Hamor; Licheng Zhang; Sergio Aguirre; Jingyuan Hu; Yichao Shen; Yitian Xu; Yang Gao; Na Zhao; Shu-Hsia Chen; Ying-Wooi Wan; Zhandong Liu; Jeffrey T Chang; Daniel Hollern; Charles M Perou; Xiang H F Zhang; Jeffrey M Rosen
Journal:  Cancer Res       Date:  2022-06-15       Impact factor: 13.312

4.  TRAF2 Deficiency in B Cells Impairs CD40-Induced Isotype Switching That Can Be Rescued by Restoring NF-κB1 Activation.

Authors:  Rachel A Woolaver; Xiaoguang Wang; Yonatan Dollin; Ping Xie; Jing H Wang; Zhangguo Chen
Journal:  J Immunol       Date:  2018-10-19       Impact factor: 5.422

5.  Epstein-Barr virus LMP2A reduces hyperactivation induced by LMP1 to restore normal B cell phenotype in transgenic mice.

Authors:  Alexandra C Vrazo; Maria Chauchard; Nancy Raab-Traub; Richard Longnecker
Journal:  PLoS Pathog       Date:  2012-04-19       Impact factor: 6.823

Review 6.  Role of TRAFs in Signaling Pathways Controlling T Follicular Helper Cell Differentiation and T Cell-Dependent Antibody Responses.

Authors:  Christophe Pedros; Amnon Altman; Kok-Fai Kong
Journal:  Front Immunol       Date:  2018-10-22       Impact factor: 7.561

Review 7.  System-Level Scenarios for the Elucidation of T Cell-Mediated Germinal Center B Cell Differentiation.

Authors:  Niels J M Verstegen; Victor Ubels; Hans V Westerhoff; S Marieke van Ham; Matteo Barberis
Journal:  Front Immunol       Date:  2021-09-20       Impact factor: 7.561

8.  Aberrant CD40-induced NF-κB activation in human lupus B lymphocytes.

Authors:  Wen Zhang; Qun Shi; Xiaotian Xu; Hua Chen; Wei Lin; Fengchun Zhang; Xiaofeng Zeng; Xuan Zhang; Denian Ba; Wei He
Journal:  PLoS One       Date:  2012-08-27       Impact factor: 3.240

9.  A genome-wide association study for natural antibodies measured in blood of Canadian Holstein cows.

Authors:  Britt de Klerk; Mehdi Emam; Kathleen A Thompson-Crispi; Mehdi Sargolzaei; Johan J van der Poel; Bonnie A Mallard
Journal:  BMC Genomics       Date:  2018-09-21       Impact factor: 3.969

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.